Inotuzumab ozogamicin (InO) is an active antibody-drug conjugate that works by delivering the chemotherapeutic payload calicheamicin to cells expressing CD22. Studies demonstrate that InO elicits high ...

Population-based cohort study identifies better treatment objectives for women with advanced-stage ovarian cancer.

The incidence of head and neck cancer increased among patients in the cannabis-related disorder group compared with patients without cannabis-related disorder (0.285% vs 0.091%, respectively).

In a retrospective study, investigators compared the risk of progression to end-stage kidney disease (ESKD) following partial nephrectomy and radical nephrectomy among patients with preoperative stage ...

Similar cancer detection rates seen for transperineal versus transrectal biopsy, but reduction in infections seen for transperineal.